Find out today what the legal world will be talking about tomorrow.
view all news & events
18.06.2020
#strong against COVID-19 - SKW Schwarz participates in Biolegis research on limitations of liability for vaccines in the EU
![](/fileadmin/_processed_/b/4/csm_AdobeStock_329762274_Impfstoff_Zulassung_a8622f03a3.jpg)
SKW Schwarz is the only German law firm to be part of the Biolegis network, a pan-European network of independent law firms with in-depth expertise in life sciences.
In this capacity, SKW Schwarz is currently participating in a major Biolegis initiative to assess national facilitations in the respective approval procedures for COVID-19 vaccines.
The initiative focuses on regulatory issues relating to drug approval and possible modifications of existing statutory provisions with respect to the fight against COVID-19. Since a draft bill is not yet available, the initiative aims to offer international clients an overview of currently existing regulatory hurdles.
Authors
![Tatjana Schroeder](/fileadmin/_processed_/e/c/csm_Schroeder_Portrait_Q_6df4c2dfc7.jpg)
![Markus Fuchs](/fileadmin/_processed_/7/1/csm_Markus_von_Fuchs_Q_2755_684a1eabb7.jpg)
![Matthias Nordmann](/fileadmin/_processed_/6/8/csm_Nordmann_Q_3561_46aafd6db5.jpg)
![Arndt Tetzlaff](/fileadmin/_processed_/3/7/csm_Tetzlaff_Q_0933_0a2e5cb04f.jpg)